首页> 外文期刊>PDA journal of pharmaceutical science and technology >Implementation of parallelism testing for four-parameter logistic model in bioassays
【24h】

Implementation of parallelism testing for four-parameter logistic model in bioassays

机译:生物测定中四参数逻辑模型并行测试的实现

获取原文
获取原文并翻译 | 示例
       

摘要

Parallelism is a prerequisite for the determination of relative potency in bioactivity assays. It involves the testing of similarity between a pair of dose-response curves of reference standard and test sample. The evaluation of parallelism is a requirement listed by both the United States Pharmacopeia (USP) and European Pharmacopeia (EP). The revised USP Chapters 〈1032〉 and 〈1034〉 suggest testing parallelism using an equivalence method. However, implementation of this method can be challenging for laboratories that lack experience in statistical analysis and software development. In this paper we present a customized assay analysis template that is developed based on a fully good manufacturing practice (GMP)-compliant software package. The template allows for automation of the USP-recommended equivalence parallelism testing method for 4PLmodel in bioassays. It makes the implementation of the USP guidance both practical and feasible. Use of the analysis template is illustrated through a practical example.
机译:平行性是确定生物活性测定中相对效力的先决条件。它涉及测试参考标准与测试样品的一对剂量反应曲线之间的相似性。并行性的评估是美国药典(USP)和欧洲药典(EP)列出的要求。修订的USP的<1032>和<1034>章建议使用等效方法测试并行性。但是,对于缺乏统计分析和软件开发经验的实验室,这种方法的实施可能具有挑战性。在本文中,我们介绍了基于完全符合良好生产规范(GMP)的软件包开发的定制化验分析模板。该模板可实现生物测定中针对4PL模型的USP推荐的当量平行性测试方法的自动化。它使实施USP指南既可行又可行。通过实际示例说明了分析模板的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号